CD8A and neoplasm: The number of activated CD8+IFNγ+ T cells in tumor‐infiltrating lymphocytes in the xenograft after L‐CTB‐hsCD80 treatment increased significantly, whereas the number of activated T cells modestly increased after L‐hsCD80 treatment, supporting our inference.